Alembic Pharmaceuticals receives USFDA approval for Loteprednol Etabonate and Tobramycin Ophthalmic…
Company secures final ANDA approval with eligibility for 180 days of CGT exclusivity
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
competitive generic therapy
Lupin launches first generic of Pred Forte in the US
Lupin has commenced shipment with a 180-day CGT exclusivity
Zydus Cadila gets 180-day exclusivity for Nelarabine injection, announces final approval from US FDA
This medication is a chemotherapy drug and used to treat certain types of leukemia and lymphoma by slowing or stopping the growth…
Glenmark gets US FDA approval for Theophylline ER Tablets, 300 mg and 450 mg
Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity on the 450 mg
Glenmark Pharma gets ANDA approval for diltiazem hydrochloride ER capsules
Glenmark Pharmaceuticals has received final approval by the United States Food and Drug Administration (US FDA) for diltiazem…